학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 82건 | 목록 1~20
Academic Journal
In Current Opinion in Pharmacology 2005 5(4):438-443
Academic Journal
Zhou Y; Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.; Jadlowsky J; Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.; Baiduc C; Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.; Klattenhoff AW; Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.; Chen Z; Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.; Bennett AD; Adaptimmune Ltd, Abingdon, United Kingdom.; Pumphrey NJ; Adaptimmune Ltd, Abingdon, United Kingdom.; Jakobsen BK; Adaptimmune Ltd, Abingdon, United Kingdom.; Immunocore Ltd., Abingdon, United Kingdom.; Riley JL; Department of Microbiology and Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Academic Journal
Holland CJ; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Crean RM; Department of Biology and Biochemistry and.; Doctoral Training Centre in Sustainable Chemical Technologies, University of Bath, Bath, United Kingdom.; Pentier JM; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; de Wet B; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Lloyd A; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Srikannathasan V; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Lissin N; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Lloyd KA; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Blicher TH; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Conroy PJ; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Hock M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Pengelly RJ; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Spinner TE; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Cameron B; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Potter EA; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Jeyanthan A; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Molloy PE; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Sami M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Aleksic M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Liddy N; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Robinson RA; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Harper S; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Lepore M; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Pudney CR; Department of Biology and Biochemistry and.; van der Kamp MW; School of Biochemistry, University of Bristol, Bristol, United Kingdom.; Rizkallah PJ; Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.; Jakobsen BK; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Vuidepot A; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Cole DK; Immunocore Ltd., Milton Park, Abingdon, United Kingdom.; Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Academic Journal
Madura F; School of Medicine, Cardiff University, Cardiff, UK.; Rizkallah PJ; School of Medicine, Cardiff University, Cardiff, UK.; Legut M; School of Medicine, Cardiff University, Cardiff, UK.; Holland CJ; School of Medicine, Cardiff University, Cardiff, UK.; Immunocore Ltd., Abingdon, UK.; Fuller A; School of Medicine, Cardiff University, Cardiff, UK.; Bulek A; School of Medicine, Cardiff University, Cardiff, UK.; Schauenburg AJ; School of Medicine, Cardiff University, Cardiff, UK.; Trimby A; School of Medicine, Cardiff University, Cardiff, UK.; Hopkins JR; School of Medicine, Cardiff University, Cardiff, UK.; Wells SA; Department of Chemical Engineering, University of Bath, Bath, UK.; Godkin A; School of Medicine, Cardiff University, Cardiff, UK.; Miles JJ; School of Medicine, Cardiff University, Cardiff, UK.; Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia.; Sami M; Immunocore Ltd., Abingdon, UK.; Li Y; Immunocore Ltd., Abingdon, UK.; Liddy N; Immunocore Ltd., Abingdon, UK.; Jakobsen BK; Immunocore Ltd., Abingdon, UK.; Loveridge EJ; School of Chemistry, Cardiff University, Cardiff, UK.; Department of Chemistry, Swansea University, Swansea, UK.; Cole DK; School of Medicine, Cardiff University, Cardiff, UK.; Immunocore Ltd., Abingdon, UK.; Sewell AK; School of Medicine, Cardiff University, Cardiff, UK.; Systems Immunity Research Institute, Cardiff University, Cardiff, UK.
Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 1273201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4141 (Electronic) Linking ISSN: 00142980 NLM ISO Abbreviation: Eur J Immunol Subsets: MEDLINE
Academic Journal
Harper J; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Adams KJ; Adaptimmune, Oxford, United Kingdom.; Bossi G; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Wright DE; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Stacey AR; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Bedke N; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Martinez-Hague R; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Blat D; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Humbert L; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Buchanan H; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Le Provost GS; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Donnellan Z; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Carreira RJ; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Paston SJ; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Weigand LU; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Canestraro M; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Sanderson JP; Adaptimmune, Oxford, United Kingdom.; Botta Gordon-Smith S; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Lowe KL; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Rygiel KA; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Powlesland AS; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Vuidepot A; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Hassan NJ; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Cameron BJ; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Jakobsen BK; Immunocore Ltd, Abingdon, Oxford, United Kingdom.; Dukes J; Immunocore Ltd, Abingdon, Oxford, United Kingdom.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Boudousquie C; Immunocore Ltd, Abingdon, Oxon, UK.; Bossi G; Immunocore Ltd, Abingdon, Oxon, UK.; Hurst JM; Immunocore Ltd, Abingdon, Oxon, UK.; Rygiel KA; Immunocore Ltd, Abingdon, Oxon, UK.; Jakobsen BK; Immunocore Ltd, Abingdon, Oxon, UK.; Hassan NJ; Immunocore Ltd, Abingdon, Oxon, UK.
Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE
Academic Journal
Silk JD; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom; jonathan.silk@enarabio.com joanna.brewer@adaptimmune.com.; Abbott RJM; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Adams KJ; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Bennett AD; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Brett S; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; Cornforth TV; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Crossland KL; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Figueroa DJ; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; Jing J; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; O'Connor C; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Pachnio A; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Patasic L; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; Peredo CE; Cell and Gene Therapy Product Development and Supply, Analytical Development, GlaxoSmithKline, Collegeville, PA.; Quattrini A; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Quinn LL; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Rust AG; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; Saini M; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Sanderson JP; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Steiner D; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; Tavano B; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Viswanathan P; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Wiedermann GE; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Wong R; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Jakobsen BK; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Britten CM; Oncology Research and Development, GlaxoSmithKline, Stevenage Herts, United Kingdom; and.; Gerry AB; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom.; Brewer JE; Adaptimmune Ltd., Milton Park, Abingdon, United Kingdom; jonathan.silk@enarabio.com joanna.brewer@adaptimmune.com.
Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Academic Journal
Rapoport AP; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Stadtmauer EA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Binder-Scholl GK; Adaptimmune Ltd, Oxford, UK.; Goloubeva O; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD USA.; Vogl DT; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lacey SF; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Badros AZ; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Garfall A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Weiss B; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Finklestein J; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD USA.; Kulikovskaya I; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Sinha SK; School of Mathematics and Statistics, Carleton University, Ottawa, Canada.; Kronsberg S; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD USA.; Gupta M; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Bond S; Cambridge Biomedical, Cambridge, Massachusetts, USA.; Melchiori L; Adaptimmune Ltd, Oxford, UK.; Brewer JE; Adaptimmune Ltd, Oxford, UK.; Bennett AD; Adaptimmune Ltd, Oxford, UK.; Gerry AB; Adaptimmune Ltd, Oxford, UK.; Pumphrey NJ; Adaptimmune Ltd, Oxford, UK.; Williams D; Adaptimmune Ltd, Oxford, UK.; Tayton-Martin HK; Adaptimmune Ltd, Oxford, UK.; Ribeiro L; Adaptimmune Ltd, Oxford, UK.; Holdich T; Adaptimmune Ltd, Oxford, UK.; Yanovich S; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Hardy N; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Yared J; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Kerr N; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Philip S; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Westphal S; The Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Siegel DL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Levine BL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Jakobsen BK; Adaptimmune Ltd, Oxford, UK.; Kalos M; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; June CH; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Coles CH; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Mulvaney RM; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Malla S; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Walker A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Smith KJ; GlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom.; Lloyd A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Lowe KL; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; McCully ML; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Martinez Hague R; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Aleksic M; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Harper J; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Paston SJ; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Donnellan Z; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Chester F; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Wiederhold K; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Robinson RA; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Knox A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Stacey AR; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Dukes J; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Baston E; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Griffin S; GlaxoSmithKline, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, United Kingdom.; Jakobsen BK; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Vuidepot A; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and.; Harper S; Immunocore, Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom; and Stephen.Harper@immunocore.com bent.jakobsen@immunocore.com.
Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Academic Journal
Bossi G; Immunocore Ltd, 57 Jubilee Avenue Milton Park, Abingdon, Oxon, OX14 4RX, UK.; Buisson SOates JJakobsen BKHassan NJ
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Jakobsen, Bent K
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어